In the United States, public and private spending on post-genomic research is rising steadily and significantly: nearly 2 billion dollars of public-sector funding per annum, essentially managed by the NIH [28] (the total budget for which will increase by 14.4% in 2001) and twice as much industrial funding.
Aux Etats-Unis, l'effort de recherche public et privé en recherche post-génomique est en constante et importante augmentation : près de 2 milliards de dollars de fonds publics par an, essentiellement gérés par les NIH [28] (dont le budget total augmentera de 14,4 % en 2001), et le double de financements industriels.